Algo version: 0.98b
Laurus Labs Limited is listed at the NSE Exchange
Laurus Labs Limited [LAURUSLABS.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Laurus Labs Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Laurus Labs Limited pays dividends. Last time was Saturday 25th of May 2024 where the investors holding the stock on Wednesday 8th of May 2024 were paid INR0.4 per share. Over the last 15 times between 2017 and 2024, Laurus Labs Limited has paid INR14.2 with an average of INR0.95 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Laurus Labs Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR70.22, you would have made a profit of INR411.13 per share or 585.49%

Yes, the average daily trading liquidity for Laurus Labs Limited is INR2.43 million. You should therefore be able to get in and out of your positions relatively fast.

Laurus Labs Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.22, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 3.18%, which is challenging.

We have calculated the inflation risk for Laurus Labs Limited to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.